{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"PsyBio Completes Reverse Take-Over Transaction - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7016mhi8jx\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/psybio-completes-reverse-take-over-transaction\/\">PsyBio Completes Reverse Take-Over Transaction<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/psybio-completes-reverse-take-over-transaction\/embed\/#?secret=7016mhi8jx\" width=\"600\" height=\"338\" title=\"&#8220;PsyBio Completes Reverse Take-Over Transaction&#8221; &#8212; Market Newsdesk\" data-secret=\"7016mhi8jx\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Common Shares Expected to Commence Trading on the TSX Venture Exchange Imminently Not for distribution to United States newswire services or for release publication,\u00a0 distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (the \u201cCompany\u201d), announces that it has completed its previously announced reverse takeover of PsyBio Therapeutics, Inc. (\u201cPsyBio\u201d), a biotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders (the \u201cReverse Takeover\u201d). The Reverse Takeover constitutes the Company&#8217;s Qualifying Transaction (as defined by Policy 2.4 of the TSX Venture Exchange (the \u201cTSXV\u201d) and was completed pursuant to &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjQ0NyMzOTg1OTYwIzUwMDA3NDc2NQ=="}